Skip to main content

MALDI Imaging Mass Spectrometry – A Novel Approach in Biomedical Research of Tissues

Buy Article:

$68.00 + tax (Refund Policy)

Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) is a powerful tool for investigating the spatial distribution of proteins and small molecules within biological specimen. This technique combines the potential of MALDI-ToF mass spectrometry with the ability to scan series of pixels across the surface of tissues, which generates multiplex space-correlated mass spectra. Numerical processing of the data allows visualization of specific molecular species and their correlation with histological image of the tissue. Hence, IMS is a multiplex untargeted analysis that enables characterization of tissue regions based on their endogenous biomolecular content. The major advantage of this technique is its potential to define tissue regions based on their molecular profiles independently of their histological and morphological characteristics given by traditional tools. IMS can detect potential cancer foci within histologically normal tissue, reveal intra-tumor heterogeneity or altered protein expression at tumor/normal tissue interface zones. IMS is an emerging technology that could fill gaps in the knowledge of spatial nature of a disease allowing better understanding of connections between structure and molecular processes.

Keywords: MALDI-ToF mass spectrometry; molecular histopathology; molecular imaging; protein distribution; proteomics

Document Type: Research Article

Publication date: 01 July 2013

More about this publication?
  • Current Proteomics research in the emerging field of proteomics is growing at an extremely rapid rate. The principal aim of Current Proteomics is to publish well-timed review articles in this fast-expanding area on topics relevant and significant to the development of proteomics. Current Proteomics is an essential journal for everyone involved in proteomics and related fields in both academia and industry.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content